Terms: = Lung cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN
55421 results:
1. Video-Assisted vs Robotic-Assisted lung Lobectomies for Operating Room Resource Utilization and Patient Outcomes.
Tupper HI; Lawson BL; Kipnis P; Patel AR; Ashiku SK; Roubinian NH; Myers LC; Liu VX; Velotta JB
JAMA Netw Open; 2024 May; 7(5):e248881. PubMed ID: 38700865
[TBL] [Abstract] [Full Text] [Related]
2. Response- and Progression-Based End Points in Trial and Observational Cohorts of Patients With NSCLC.
Lu Y; Langerman SS; McCain E; Magee K; Maund SL; Srivastava MK; Samant M
JAMA Netw Open; 2024 May; 7(5):e249286. PubMed ID: 38700864
[TBL] [Abstract] [Full Text] [Related]
3. Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
Lou J; Gong B; Li Y; Guo Y; Li L; Wang J; Liu W; You Z; Zhang H; Pan F; Liang B; Yang L; Zhou G
Front Immunol; 2024; 15():1332303. PubMed ID: 38698843
[TBL] [Abstract] [Full Text] [Related]
4. Improving image quality of sparse-view lung tumor CT images with U-Net.
Ries A; Dorosti T; Thalhammer J; Sasse D; Sauter A; Meurer F; Benne A; Lasser T; Pfeiffer F; Schaff F; Pfeiffer D
Eur Radiol Exp; 2024 May; 8(1):54. PubMed ID: 38698099
[TBL] [Abstract] [Full Text] [Related]
5. lung cancer-specific symptoms and fear of cancer recurrence among recurrence-free non-small cell lung cancer survivors.
Lee G; Ahn A; Lee D; Kim TE; Kong S; Kang D; Kim HK; Shim YM; Cho J
Support Care Cancer; 2024 May; 32(5):322. PubMed ID: 38695959
[TBL] [Abstract] [Full Text] [Related]
6. Primary lung cancer in children and adolescents.
Chen Q; Cheng J; Wang L; Lv X; Hu J
J Cancer Res Clin Oncol; 2024 May; 150(5):225. PubMed ID: 38695944
[TBL] [Abstract] [Full Text] [Related]
7. Contrast-enhanced Imaging in Peripheral Pulmonary Lesions: The Role in US-guided Biopsies.
Wang XY; Yuan ZF; Gan KH; Zhong Y; Huang JX; Huang WJ; Xie YH; Pei XQ
Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230234. PubMed ID: 38695742
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and safety of different immunotherapies combined with chemotherapy as first-line therapy in patients with small cell lung cancer: a network meta-analysis.
Gong S; Li Q; Yu X; Yang S
Front Immunol; 2024; 15():1362537. PubMed ID: 38694505
[TBL] [Abstract] [Full Text] [Related]
9. Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice.
Huang X; Pang G; Mao Z; Li B; Teng Z; Yang Y; Qiu Z; Chen X; Wang P
Clin Respir J; 2024 May; 18(5):e13761. PubMed ID: 38693705
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Implications of Small Cell lung cancer Transcriptional Subtyping for CNS Metastases.
Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
[TBL] [Abstract] [Full Text] [Related]
11. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
12. Stem-like CD8 T cells in stage I lung adenocarcinoma as a prognostic biomarker: A preliminary study.
Sang J; Liu P; Wang M; Xu F; Ma J; Wei Z; Ye X
J Cancer Res Ther; 2024 Apr; 20(2):669-677. PubMed ID: 38687939
[TBL] [Abstract] [Full Text] [Related]
13. Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma.
Huang S; Kang X; Wang C; Zhang W; Jiang J; Kang Z; Yang S; Chen J; Chen F; Li W
J Cancer Res Ther; 2024 Apr; 20(2):658-664. PubMed ID: 38687937
[TBL] [Abstract] [Full Text] [Related]
14. Microwave ablation combined with percutaneous vertebroplasty for treating painful non-small cell lung cancer with spinal metastases under real-time temperature monitoring.
Wu L; Hu M; Li P; Man Q; Yuan Q; Zhang X; Qiu Y; Chen L; Fan J; Zhang K
J Cancer Res Ther; 2024 Apr; 20(2):540-546. PubMed ID: 38687923
[TBL] [Abstract] [Full Text] [Related]
15. Incidence of thromboembolic events in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Yang M; Cao H; Wang C; Yu C; Sun P
J Cancer Res Ther; 2024 Apr; 20(2):509-521. PubMed ID: 38687920
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor.
Hua X; Feng W; Ye M; Lai M; Yu X; Sun M; Li J; Ai R; He Y; Cai L; Shi C; Liu X
Cancer Med; 2024 May; 13(9):e7206. PubMed ID: 38686619
[TBL] [Abstract] [Full Text] [Related]
17. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
Saberzadeh-Ardestani B; Khosravi AA; Mansour-Ghanaei F; Vahedi H; Baniasadi N; Seyyedmajidi M; Parhizkar B; Hormati A; Naghshbandi SJ; Matin S; Hassan Zadeh AA; Taghvaei T; Bahrami M; Rafeey M; Ahadi M; Vossoughinia H; Muosavi H; Gheibi S; Hosseini-Hemmatabadi RS; Yazdanbod A; Matinkhah S; Sheikh Esmaeili F; Fakheri H; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Farahmand F; Najafi M; Alimadadi H; Malekzadeh M; Anushiravani A; Kasaeian A; Alatab S; Sadeghi A; Radmard AR; Kolahdoozan S; Rajabi Z; Sima AR
Arch Iran Med; 2024 Apr; 27(4):183-190. PubMed ID: 38685844
[TBL] [Abstract] [Full Text] [Related]
18. Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study.
Yang W; Fan X; Li W; Chen Y
Clin Respir J; 2024 May; 18(5):e13764. PubMed ID: 38685730
[TBL] [Abstract] [Full Text] [Related]
19. Decoding dynamic interactions between EGFR-TKD and DAC through computational and experimental approaches: A novel breakthrough in lung melanoma treatment.
Meher RK; Mir SA; Singh K; Mukerjee N; Nayak B; Kumer A; Zughaibi TA; Khan MS; Tabrez S
J Cell Mol Med; 2024 May; 28(9):e18263. PubMed ID: 38685671
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis, molecular docking studies and biological evaluation of N-(4-oxo-2-(trifluoromethyl)-4H-chromen-7-yl) benzamides as potential antioxidant, and anticancer agents.
Jorepalli S; Adikay S; Chinthaparthi RR; Gangireddy CSR; Koduru JR; Karri RR
Sci Rep; 2024 Apr; 14(1):9866. PubMed ID: 38684797
[TBL] [Abstract] [Full Text] [Related]
[Next]